[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596658":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":46,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":69,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intrauterine Diseases Cohort",null,"Disease-specific cohort for uterine cavity diseases",[13],"Other: No intervention (observational study)",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"No intervention (observational study)",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Wen W Wang, Dr.","CONTACT","+86 15927167698","petrawang@163.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430000","China","CN",{"type":34,"coordinates":35},"Point",[36,37],114.26667,30.58333,{"lat":37,"lon":36},[40,44],{"name":41,"role":21,"phone":42,"phoneExt":10,"email":43},"Pu Zhou","+86-027-83662379","tongjihlunli@163.com",{"name":20,"role":45,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Wenwen Wang","Clinical Professor","100596658","cohort-study-of-intrauterine-diseases-100596658",false,"NCT07048327","Cohort Study of Intrauterine Diseases","TJ Intrauterin","Inclusion Criteria:\n\n* Age: 18-80 years;\n* Patients requiring hysteroscopy or diagnostic curettage for intrauterine pathologies (e.g., endometrial hyperplasia, endometrial polyps, submucosal uterine fibroids, adenomyosis, or endometrial malignancies);\n* Willing and able to comply with follow-up requirements;\n* Signed informed consent obtained.\n\nExclusion Criteria:\n\n* Concurrent participation in other drug clinical trials;\n* Contraindications to or inability to tolerate hysteroscopy\u002Fcurettage procedures;\n* Unwilling or unable to provide informed consent;\n* Unwilling or unable to adhere to study protocols.","FEMALE","18 Years","80 Years",{"count":61,"type":62},2000,"ESTIMATED","OBSERVATIONAL","\"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases.\"",[66,67,68],"Endometrial Cancer","Endometrial Hyperplasia","Endometrial Polyps",[70,66,67,68,71],"Intrauterine diseases","Cohort Study","2025-06-24",{"date":74,"type":75},"2025-07-02","ACTUAL",{"date":77,"type":62},"2025-07",{"date":79,"type":62},"2028-07",{"name":48,"class":6},1]